Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019)
Akebia Therapeutics (AKBA) posted quarterly Short-term Investments of $245000.0 for Q4 2019, down 99.58% year-over-year from $58.4 million in Q4 2018, and down 98.92% quarter-over-quarter from $22.7 million in Q3 2019.
Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Short-term Investments for 7 consecutive years, with $245000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Short-term Investments fell 99.58% year-over-year to $245000.0; the TTM figure through Dec 2019 stood at $245000.0 (down 99.58% YoY), while the FY2019 annual figure was $245000.0, down 99.58% from the prior year.
- Short-term Investments eased to $245000.0 in Q4 2019 per AKBA's latest filing, from $22.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $240.1 million in Q3 2017 and bottomed at $245000.0 in Q4 2019.
- Historically, Short-term Investments has averaged $124.6 million across 5 years, with a median of $100.4 million in 2016.
- Annual changes were most pronounced in 2015 — Short-term Investments surged 574.61% — and 2019, when it tumbled 99.58%.
- Akebia Therapeutics' Short-term Investments stood at $88.7 million in 2015, then decreased by 17.67% to $73.0 million in 2016, then surged by 139.43% to $174.8 million in 2017, then sank by 66.57% to $58.4 million in 2018, then sank by 99.58% to $245000.0 in 2019.
- Business Quant data shows AKBA's Short-term Investments at $245000.0 in Q4 2019, $22.7 million in Q3 2019, and $49.6 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 245,000.00 |
| Sep 30, 2019 | 22.73 Mn |
| Jun 30, 2019 | 49.55 Mn |
| Mar 31, 2019 | 105.30 Mn |
| Dec 31, 2018 | 58.43 Mn |
| Sep 30, 2018 | 227.71 Mn |
| Jun 30, 2018 | 238.60 Mn |
| Mar 31, 2018 | 234.86 Mn |
| Dec 31, 2017 | 174.80 Mn |
| Sep 30, 2017 | 240.11 Mn |
| Jun 30, 2017 | 195.83 Mn |
| Mar 31, 2017 | 164.56 Mn |
| Dec 31, 2016 | 73.01 Mn |
| Sep 30, 2016 | 95.49 Mn |
| Jun 30, 2016 | 142.47 Mn |
| Mar 31, 2016 | 173.59 Mn |
| Dec 31, 2015 | 88.68 Mn |
| Sep 30, 2015 | 90.75 Mn |
| Jun 30, 2015 | 76.54 Mn |
| Mar 31, 2015 | 39.34 Mn |